Schedule 13G ownership disclosure

CTI BIOPHARMA CORP

Security class unavailable · CUSIP: 12648L601

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,726,579
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-19-000108
Form type
SC 13G/A
Filer
CTI BIOPHARMA CORP
CIK
CIK 891293
Filed
Feb 13, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub